The relatively high level of palmitic acid (22 mol%) in cottonseeds may be due in part to the activity of a palmitoyl-acyl carrier protein (ACP) thioesterase (PATE). In embryo extracts, PATE activity was highest at the maximum rate of reserve accumulation (oil and protein). The cotton FatB mRNA transcript abundance also peaked during this developmental stage, paralleling the profiles of PATE enzyme activity and seed oil accumulation. A cotton FatB cDNA clone was isolated by screening a cDNA library with a heterologous Arabidopsis FatB probe (Pirtle et al., 1999, Plant and Cell Physiology 40: 155-163). The predicted amino acid sequence of the cotton PATE preprotein had 63% identity to the Arabidopsis FatB thioesterase sequence, suggesting that the cotton cDNA clone probably encoded a FatB-type thioesterase. When acyl-CoA synthetase-minus E. coli mutants expressed the cotton cDNA, an increase in 16:0 free fatty acid content was measured in the culture medium. In addition, acyl-ACP thioesterase activity assays in E. coli lysates revealed that there was a preference for palmitoyl-ACP over oleoyl-ACP in vitro, indicating that the cotton putative FatB cDNA encoded a functional thioesterase with a preference for saturated acyl-ACPs over unsaturated acyl-ACPs (FatA). Overexpression of the FatB cDNA in transgenic cotton resulted in elevated levels of palmitic acid in transgenic somatic embryos compared to control embryos. Expression of the anti-sense FatB cDNA in transgenic cotton plants produced some plants with a dwarf phenotype. These plants had significantly smaller mature leaves, all with smaller cells, suggesting that these plants may have less palmitic acid available for incorporation into extraplastidial membrane lipids during cell expansion. Thus manipulation of FatB expression in cotton directly influenced palmitic acid levels. Collectively, data presented in this dissertation support the hypothesis that there indeed is a palmitoyl-ACP thioesterase in cotton, encoded by the isolated FatB cDNA, which plays a major role in regulating palmitic acid content of extraplastidial complex glycerolipids. This work forms the basis for future studies of the influence of palmitic acid content on plant membrane function and provides a key target for the metabolic engineering of palmitic acid levels in storage oils of developing cottonseeds.

Em bovinos de corte, maiores diâmetros do folículo pré-ovulatório (FPO) e as subsequentes altas concentrações de progesterona [P4] aumentam o crescimento do concepto e a taxa de prenhez. Formulou-se a hipótese que a modulação do tamanho do FPO e [P4] no diestro subsequente à ovulação do FPO estimulam a expressão endometrial de transcritos e proteínas da famílias das Solute Carrier Proteins (SLC) que estão relacionadas ao transporte de glicose. Vacas Nelore (n=60), solteiras e ciclando receberam duas injeções de PGF2&alpha; (PGF; 0,5mg; i.m.) com intervalo de 14 dias. Dez dias após (dia -10; D-10), receberam um dispositivo intravaginal liberador de P4 e benzoato de estradiol (2mg; i.m.). Para modular o crescimento do FPO e alterar a produção de P4 pós-ovulação, no D-10 os animais receberam PGF (grupo alta P4; AP) ou não (grupo baixa P4; BP). Dispositivos foram removidos e PGF injetada 60 a 42 horas antes da indução da ovulação para o grupo AP e 48 a 30 horas antes da indução para o grupo BP e ovulações foram induzidas com GnRH (buserelina; 10&micro;g; i.m.) no D0. Crescimento e ovulação do FPO e formação do CL foram avaliados por ultrassom e [P4] medidas por radioimunoensaio. No D7 os animais que ovularam foram abatidos (AP, N=18 e BP, N=18), o endométrio foi dissecado e submetido à extração de RNA total para análises de qPCR, extração de proteínas totais para análises de western blotting e incluído em parafina para análises de imunohistoquímica. Diferença entre as médias dos grupos foi determinada pelo teste t de student. O diâmetro máximo do FPO (média ± erro padrão da média; 12,8±0,4 vs. 11,1±0,4mm) foi maior no grupo AP (P<0,01). A [P4] no D7 foi maior no grupo AP (4,5±1,0 ng/mL vs. 3,3±1,1 ng/mL; P<0,05). As concentrações relativas dos transcritos que codificam SLCs foram determinadas por qPCR, usando a ciclofilina como controle endógeno. Não houve diferença na expressão de SLC2A1 (0,91±0,04 vs. 1,02±0,07), SLC2A3 (1,14±0,16 vs. 1,05±0,1), SLC2A4 (1,20±0,14 vs. 1,01±0,05), SLC2A5 (0,95±0,12 vs. 1,04±0,12), SLC5A1 (1,35±0,25 vs. 1,49±0,44), ATP1A2 (1,29±0,17 vs. 1,03±0,1), ATP1B2 (1,20±0,11 vs. 1,06±0,1), SLC37A4 (1,16±0,16 vs. 1,1±0,12), entre os grupos AP e BP respectivamente (P>0.05). Também não foi possível identificar diferença na quantidade proteica de SLC2A1 no endométrio dos animais do grupo AP em relação ao grupo BP. SLC2A1 foi identificada na membrana basal no epitélio luminal (EL), epitélio glandular (EG) e no estroma uterino dos animais. SLC2A4 foi identificada na membrana basal e membrana apical no EL, EG e no estroma uterino dos animais. Em conclusão, a modulação do tamanho do FPO e [P4] no diestro não afetaram a expressão gênica ou proteica dos transportadores de glicose. É possível que ao invés da expressão gênica ou proteica, a atividade transportadora das SLCs, ou ainda, a expressão e função de genes relacionados ao metabolismo de carboidratos, sejam regulados pelo ambiente endócrino peri-ovulatório em vacas. / In beef cattle, changes in the peri-ovulatory endocrine milieu are associated with conceptus growth and fertility. A large size of the pre-ovulatory follicle (POF) and resulting elevated progesterone (P4) concentrations during diestrus affect pregnancy rates positively. Our hypothesis is that modulation of POF size and diestrus P4 concentrations regulate nutrient availability in the uterus. Specifically, optimal glucose concentrations in the histotroph are required for adequate embryo growth during early gestation. The objective was to determine if POF size and resulting P4 concentrations during the first week of diestrus influence gene expression of Solute Carrier Protein (SLC) families that are related to glucose transport. Cyclic, non-lactating Nelore cows received two injections of cloprostenol (PGF; 0.5mg; i.m.) 14 days apart. Ten days later (day -10; D-10), cows received a P4-releasing device along with estradiol benzoate (2mg; i.m.). To modulate the growth of the POF and alter post-ovulatory P4 production, on D-10 animals received PGF (high post-ovulatory P4 group; HP) or not (low post-ovulatory P4 group; LP). The P4-releasing devices were removed and PGF injected 60 to 42 hours before the ovulation induction in the HP group and 48 to 30 hours before the ovulation induction in the LP group. Ovulation was induced with buserelin (GnRH; 10&micro;g; i.m.) on D0. Diameter of POF and ovulation were assessed by ultrasonography starting onD- 2. From D1 to D7, plasma was obtained for measurement of P4 concentration. On D7, cows that ovulated were slaughtered (HP, n=18 and LP, n=18) and endometrium was dissected and subjected total RNA extraction for qPCR analyzes, total protein extraction for western blotting analyzes and included in paraffin for imunohistochemical analyzes. Differences between group means were determined by student\'s t test. Maximum diameter of the POF (mean ± SEM; 12.8±0.4 vs. 11.1±0.4mm) was greater in HP vs. LP (P<0.01). Progesterone concentration on D7 was larger on the HP group (4.5±1.0 ng/mL and 3.3±1.1 ng/mL; P<0.05). Relative concentrations of transcripts coding for facilitative sugar transporters (SLC2A1, SLC2A3, SLC2A4 and SLC2A5), a sodium-dependent glucose co-transporter (SLC5A1) and other transporters related to glucose uptake (ATP1A2, ATP1B2, SLC37A4) were determined by qPCR, using cyclophilin as the endogenous control gene. There were no significant differences in expression of SLC2A1 (mean ± SEM;0.91±0.04 vs. 1.02±0.07), SLC2A3 (1.14±0.16 vs. 1.05±0.1), SLC2A4 (1.20±0.14 vs. 1.01±0.05), SLC2A5 (0.95±0.12 vs. 1.04±0.12), SLC5A1 (1.35±0.25 vs. 1.49±0.44), ATP1A2 (1.29±0.17 vs. 1.03±0.1), ATP1B2 (1.20±0.11 VS. 1.06±0.1) ,SLC37A4 (1.16±0.16 vs. 1.1±0.12), between HP and LP, respectively (P>0.05). There was no difference in the abundance of SLC2A1 protein between groups. The SLC2A1 protein was localized in the luminal epithelium (LE), glandular epithelium (GE) and uterine stroma (US) of animals. The SLC2A4 protein was localized on the basal and apical membrane of the LE, GE and US of animals. In conclusion, modulation of POF size and diestrus P4 concentrations did not affect the expression of glucose transporter genes or proteins. It is possible that activity of SLC proteins rather than gene expression, or alternatively, expression and function of genes related to carbohydrate metabolism, are regulated by the peri-ovulatory endocrine milieu in cows.

Em bovinos de corte, maiores diâmetros do folículo pré-ovulatório (FPO) e as subsequentes altas concentrações de progesterona [P4] aumentam o crescimento do concepto e a taxa de prenhez. Formulou-se a hipótese que a modulação do tamanho do FPO e [P4] no diestro subsequente à ovulação do FPO estimulam a expressão endometrial de transcritos e proteínas da famílias das Solute Carrier Proteins (SLC) que estão relacionadas ao transporte de glicose. Vacas Nelore (n=60), solteiras e ciclando receberam duas injeções de PGF2&alpha; (PGF; 0,5mg; i.m.) com intervalo de 14 dias. Dez dias após (dia -10; D-10), receberam um dispositivo intravaginal liberador de P4 e benzoato de estradiol (2mg; i.m.). Para modular o crescimento do FPO e alterar a produção de P4 pós-ovulação, no D-10 os animais receberam PGF (grupo alta P4; AP) ou não (grupo baixa P4; BP). Dispositivos foram removidos e PGF injetada 60 a 42 horas antes da indução da ovulação para o grupo AP e 48 a 30 horas antes da indução para o grupo BP e ovulações foram induzidas com GnRH (buserelina; 10&micro;g; i.m.) no D0. Crescimento e ovulação do FPO e formação do CL foram avaliados por ultrassom e [P4] medidas por radioimunoensaio. No D7 os animais que ovularam foram abatidos (AP, N=18 e BP, N=18), o endométrio foi dissecado e submetido à extração de RNA total para análises de qPCR, extração de proteínas totais para análises de western blotting e incluído em parafina para análises de imunohistoquímica. Diferença entre as médias dos grupos foi determinada pelo teste t de student. O diâmetro máximo do FPO (média ± erro padrão da média; 12,8±0,4 vs. 11,1±0,4mm) foi maior no grupo AP (P<0,01). A [P4] no D7 foi maior no grupo AP (4,5±1,0 ng/mL vs. 3,3±1,1 ng/mL; P<0,05). As concentrações relativas dos transcritos que codificam SLCs foram determinadas por qPCR, usando a ciclofilina como controle endógeno. Não houve diferença na expressão de SLC2A1 (0,91±0,04 vs. 1,02±0,07), SLC2A3 (1,14±0,16 vs. 1,05±0,1), SLC2A4 (1,20±0,14 vs. 1,01±0,05), SLC2A5 (0,95±0,12 vs. 1,04±0,12), SLC5A1 (1,35±0,25 vs. 1,49±0,44), ATP1A2 (1,29±0,17 vs. 1,03±0,1), ATP1B2 (1,20±0,11 vs. 1,06±0,1), SLC37A4 (1,16±0,16 vs. 1,1±0,12), entre os grupos AP e BP respectivamente (P>0.05). Também não foi possível identificar diferença na quantidade proteica de SLC2A1 no endométrio dos animais do grupo AP em relação ao grupo BP. SLC2A1 foi identificada na membrana basal no epitélio luminal (EL), epitélio glandular (EG) e no estroma uterino dos animais. SLC2A4 foi identificada na membrana basal e membrana apical no EL, EG e no estroma uterino dos animais. Em conclusão, a modulação do tamanho do FPO e [P4] no diestro não afetaram a expressão gênica ou proteica dos transportadores de glicose. É possível que ao invés da expressão gênica ou proteica, a atividade transportadora das SLCs, ou ainda, a expressão e função de genes relacionados ao metabolismo de carboidratos, sejam regulados pelo ambiente endócrino peri-ovulatório em vacas. / In beef cattle, changes in the peri-ovulatory endocrine milieu are associated with conceptus growth and fertility. A large size of the pre-ovulatory follicle (POF) and resulting elevated progesterone (P4) concentrations during diestrus affect pregnancy rates positively. Our hypothesis is that modulation of POF size and diestrus P4 concentrations regulate nutrient availability in the uterus. Specifically, optimal glucose concentrations in the histotroph are required for adequate embryo growth during early gestation. The objective was to determine if POF size and resulting P4 concentrations during the first week of diestrus influence gene expression of Solute Carrier Protein (SLC) families that are related to glucose transport. Cyclic, non-lactating Nelore cows received two injections of cloprostenol (PGF; 0.5mg; i.m.) 14 days apart. Ten days later (day -10; D-10), cows received a P4-releasing device along with estradiol benzoate (2mg; i.m.). To modulate the growth of the POF and alter post-ovulatory P4 production, on D-10 animals received PGF (high post-ovulatory P4 group; HP) or not (low post-ovulatory P4 group; LP). The P4-releasing devices were removed and PGF injected 60 to 42 hours before the ovulation induction in the HP group and 48 to 30 hours before the ovulation induction in the LP group. Ovulation was induced with buserelin (GnRH; 10&micro;g; i.m.) on D0. Diameter of POF and ovulation were assessed by ultrasonography starting onD- 2. From D1 to D7, plasma was obtained for measurement of P4 concentration. On D7, cows that ovulated were slaughtered (HP, n=18 and LP, n=18) and endometrium was dissected and subjected total RNA extraction for qPCR analyzes, total protein extraction for western blotting analyzes and included in paraffin for imunohistochemical analyzes. Differences between group means were determined by student\'s t test. Maximum diameter of the POF (mean ± SEM; 12.8±0.4 vs. 11.1±0.4mm) was greater in HP vs. LP (P<0.01). Progesterone concentration on D7 was larger on the HP group (4.5±1.0 ng/mL and 3.3±1.1 ng/mL; P<0.05). Relative concentrations of transcripts coding for facilitative sugar transporters (SLC2A1, SLC2A3, SLC2A4 and SLC2A5), a sodium-dependent glucose co-transporter (SLC5A1) and other transporters related to glucose uptake (ATP1A2, ATP1B2, SLC37A4) were determined by qPCR, using cyclophilin as the endogenous control gene. There were no significant differences in expression of SLC2A1 (mean ± SEM;0.91±0.04 vs. 1.02±0.07), SLC2A3 (1.14±0.16 vs. 1.05±0.1), SLC2A4 (1.20±0.14 vs. 1.01±0.05), SLC2A5 (0.95±0.12 vs. 1.04±0.12), SLC5A1 (1.35±0.25 vs. 1.49±0.44), ATP1A2 (1.29±0.17 vs. 1.03±0.1), ATP1B2 (1.20±0.11 VS. 1.06±0.1) ,SLC37A4 (1.16±0.16 vs. 1.1±0.12), between HP and LP, respectively (P>0.05). There was no difference in the abundance of SLC2A1 protein between groups. The SLC2A1 protein was localized in the luminal epithelium (LE), glandular epithelium (GE) and uterine stroma (US) of animals. The SLC2A4 protein was localized on the basal and apical membrane of the LE, GE and US of animals. In conclusion, modulation of POF size and diestrus P4 concentrations did not affect the expression of glucose transporter genes or proteins. It is possible that activity of SLC proteins rather than gene expression, or alternatively, expression and function of genes related to carbohydrate metabolism, are regulated by the peri-ovulatory endocrine milieu in cows.

Während die Wirkung der meisten gebräuchlichen Antibiotika auf einer Beeinträchtigung wichtiger bakterieller Prozesse beruht, wirken manche Substanzen durch die Störung der Zellmembran-Struktur. Da Fettsäuren ein essentieller Bestandteil von Membran-Phospholipiden sind, stellt die bakterielle Fettsäurebiosynthese II (FAS-II) einen relativ wenig erforschten, aber dennoch vielversprechenden Angriffspunkt für die Entwicklung neuer Antibiotika dar. Das wichtige Antituberkulotikum Isoniazid blockiert die mykobakterielle Fettsäurebiosynthese und ruft dadurch morphologische Änderungen sowie letztlich die Lyse des Bakteriums hervor. Eine wichtige Erkenntnis war, dass Isoniazid den letzten Schritt des FAS-II Elongationszyklus inhibiert, der durch die Enoyl-ACP Reduktase katalysiert wird. Darauf aufbauend wurden mehrere Programme ins Leben gerufen, die sich zum Ziel gesetzt hatten, neue Moleküle zu entwickeln, welche dieses Protein verschiedener Pathogene hemmen. Die S. aureus Enoyl-ACP Reduktase (saFabI) ist von besonders großem Interesse, da drei vielversprechende Inhibitoren dieses Proteins entwickelt werden konnten, die momentan in klinischen Studien eingehend untersucht werden. Trotz dieser Erfolgsaussichten waren zum Zeitpunkt, als die vorliegenden Arbeiten aufgenommen wurden, keine Kristallstrukturen von saFabI öffentlich verfügbar. Daher war es eines der Hauptziele dieser Doktorarbeit, auf der Basis von kristallographischen Experimenten atomar aufgelöste Modelle für dieses wichtige Protein zu erzeugen. Durch die Entwicklung einer verlässlichen Methode zur Kristallisation von saFabI im Komplex mit NADP+ und Diphenylether-Inhibitoren konnten Kristallstrukturen von 17 verschiedenen ternären Komplexen gelöst werden. Weitere kristallographische Experimente ergaben zwei apo-Strukturen sowie zwei Strukturen von saFabI im Komplex mit NADPH und 2-Pyridon-Inhibitoren. Basierend auf der nun bekannten saFabI-Struktur konnten Molekulardynamik-Simulationen durchgeführt werden, um zusätzliche Erkenntnisse über die Flexibilität dieses Proteins zu erhalten. Die so gewonnenen Informationen über die Struktur und Beweglichkeit des Enzyms dienten in Folge als ideale Grundlage dafür, den Erkennungsprozess von Substrat und Inhibitor zu verstehen. Besonders bemerkenswert dabei ist, dass die verschiedenen saFabI Kristallstrukturen Momentaufnahmen entlang der Reaktionskoordinate der Ligandenbindung und des Hydrid-Transfers repräsentieren. Dabei verschließt der so genannte Substratbindungsloop das aktive Zentrum des Enzyms allmählich. Die außergewöhnlich hohe Mobilität von saFabI konnte durch molekulardynamische Simulationen bestätigt werden. Dies legt nahe, dass die beobachteten Änderungen der Konformation tatsächlich an der Aufnahme und Umsetzung des Substrates beteiligt sind. Eine Kette von Wassermolekülen zwischen dem aktiven Zentrum und einer wassergefüllten Kavität im Inneren des Tetramers scheint für die Beweglichkeit des Substratbindungsloops und somit für die katalysierte Reaktion von entscheidender Bedeutung zu sein. Außerdem wurde die erstaunliche Beobachtung gemacht, dass der adaptive Substratbindungsprozess mit einem Dimer-Tetramer Übergang gekoppelt ist, welcher die beobachtete positive Kooperativität der Ligandenbindung erklären kann. Alles in allem weist saFabI im Vergleich zu FabI Proteinen aus anderen Organismen mehrere außergewöhnliche Eigenschaften auf, die für die Synthese von verzweigten Fettsäuren nötig sein könnten, welche wiederum für die Überlebensfähigkeit von S. aureus im Wirt von Bedeutung sind. Diese Erkenntnis könnte erklären, warum S. aureus selbst bei Anwesenheit von exogenen Fettsäuren von FAS-II Inhibitoren abgetötet werden kann. Somit können die gewonnenen atomaren saFabI Modelle einen entscheidenden Beitrag zur Entwicklung neuer Hemmstoffe dieses validierten Angriffszieles leisten. Tatsächlich konnten die neuen Strukturen genutzt werden, um die Bindungsstärken sowie die Verweilzeiten verschiedener saFabI Inhibitoren molekular zu erklären. Die Struktur von saFabI im Komplex mit dem 2-Pyridon Inhibitor CG400549 hingegen enthüllte spezifische Wechselwirkungen in der geweiteten Bindetasche des S. aureus Enzyms, welche das geringe Aktivitätsspektrum dieses derzeit klinisch erprobten Inhibitors erklären. Diese Studien schaffen somit eine ideale Voraussetzung für die Entwicklung neuer wirksamer saFabI Inhibitoren, was am Beispiel des 4-Pyridons PT166 belegt werden kann. Im Rahmen der vorliegenden Dissertation konnten außerdem die Strukturen des Enzyms KasA im Komplex mit mehreren Derivaten des Naturstoffs Thiolactomycin gelöst werden. / Whereas most currently used antibiotics act by interfering with essential bacterial processes, a smaller group of antibacterials disturbs the integrity of the cell membrane. Since fatty acids are a vital component of membrane phospholipids, the type-II fatty acid biosynthesis pathway (FAS-II) of bacteria constitutes a promising drug target. The front-line anti-tuberculosis prodrug isoniazid blocks the FAS-II pathway in M. tuberculosis thereby leading to morphological changes and finally to cell lysis. When it became evident that the enoyl-ACP reductase in the FAS-II pathway is the target of the activated isoniazid, several programs were initiated to develop novel inhibitors directed against this protein in different pathogens. The S. aureus enoyl-ACP reductase (saFabI) is of particular interest since three promising drug candidates inhibiting this homologue have reached clinical trials. However, despite these prospects, no crystal structures of saFabI were publicly available at the time the present work was initiated. Thus, one major goal of this thesis was the generation of high-resolution atomic models by means of X-ray crystallography. The development of a highly reproducible approach to co-crystallize saFabI in complex with NADP+ and diphenyl ether-based inhibitors led to crystal structures of 17 different ternary complexes. Additional crystallographic experiments permitted the view into two apo-structures and two atomic models of saFabI in complex with NADPH and 2-pyridone inhibitors. Based on the established saFabI structure, molecular dynamics (MD) simulations were performed to improve our understanding of the conformational mobility of this protein. Taken together, these investigations of the saFabI structure and its flexibility served as an ideal platform to address important questions surrounding substrate and inhibitor recognition by this enzyme. Intriguingly, our saFabI structures provide several vastly different snapshots along the reaction coordinate of ligand binding and hydride transfer, including the closure of the flexible substrate binding loop (SBL). The extraordinary mobility of saFabI was confirmed by MD simulations suggesting that conformational motions indeed play a pivotal role during substrate delivery and turnover. A water chain linking the active site with a water-basin inside the homo-tetrameric enzyme was found likely to be crucial for the closure and opening of the SBL and, thus, for the catalyzed reaction. Notably, the induced-fit ligand binding process involves a dimer-tetramer transition, which could be related to the observed positive cooperativity of cofactor and substrate binding. Overall, saFabI displays several unique characteristics compared to FabI proteins from other organisms that might be necessary for the synthesis of branched-chain fatty acids, which in turn are required for S. aureus fitness in vivo. This finding may explain why S. aureus is sensitive to FAS-II inhibitors even in the presence of exogenous fatty acids. Accordingly, saFabI remains a valid drug target and our structures can be used as a molecular basis for rational drug design efforts. In fact, binding affinity trends of diphenyl ether inhibitors and, more importantly, the correlated residence times could be rationalized at the molecular level. Furthermore, the structure of saFabI in complex with the 2-pyridone inhibitor CG400549 revealed unique interactions in the wider binding crevice of saFabI compared to other FabI homologues explaining the narrow activity spectrum of this clinical candidate with proven human efficacy. In summary, these studies provide an ideal platform for the development of new, effective saFabI inhibitors as exemplified by the promising 4-pyridone PT166. In the context of this dissertation, crystal structures of the condensing enzyme KasA in complex with several analogs of the naturally occurring inhibitor thiolactomycin have been solved.

The haemolymph of the adult Colorado potato beetle, Lepinotarsa decemlineata Say, contains a high molecular weight (MW > 200,000) JH-III specific binding protein. The Kd value of the protein for racemic JH-III is 1.3 ± 0.2 × 10−7 M. It has a lower affinity for racemic JH-I and it does not bind JH-III-diol or JH-III-acid. The binding protein does discriminate between the enantiomers of synthetic, racemic JH-III as was determined by stereochemical anaysis of the bound and the free JH-III. Incubation of racemic JH-III with crude haemolymph results in preferential formation of (10S)-JH-III-acid, the unnatural configuration. The JH-esterase present in L. decemlineata haemolymph is not enantioselective. It is concluded that the most important function of the binding protein is that of a specific carrier, protecting the natural hormone against degradation by esterases. The carrier does not protect JH-I as efficiently as the lower homologue.

Oleic acid (18:1) is one of the important monounsaturated fatty acids, which is synthesized upon desaturation of stearic acid and this reaction is catalyzed by the SSI2 encoded stearoyl-acyl-carrier-protein-desaturase. A mutation in SSI2 leads to constitutive activation of salicylic acid (SA)-mediated defense responses. Consequently, these plants accumulate high levels of SA and show enhanced resistance to bacterial and oomycete pathogens. Replenishing 18:1 levels in ssi2 plants, via a second site mutation in GLY1 encoded glycerol-3-phosphate (G3P) dehydrogenase, suppresses all the ssi2-triggered phenotypes. Study of mechanism(s) underlying gly1-mediated suppression of ssi2 phenotypes showed that 18:1 levels are regulated via acylation with G3P and a balance between G3P and 18:1 is critical for the regulation of defense signaling pathways. To establish a role for 18:1 and G3P during host defense, interaction between Colletotrichum higginsianum and Arabidopsis was studied. Resistance to C. higginsianum correlated with host G3P levels. The gly1 plants showed increased susceptibility while act1 plants, defective in utilization of G3P, showed enhanced resistance. Plant overexpessing GLY1 showed enhanced resistance in both wild type as well as camalexin deficient backgrounds. Together, these results suggested that G3P conferred resistance acted downstream or independent of camalexin. Exogenous application of glycerol lowered 18:1 levels and produced ssi2-like phenotypes in wild-type plants. Furthermore, glycerol application or the ssi2 mutation produced similar phenotypes in fatty acid desaturation mutants and mutants defective in SA/resistance gene signaling. Expression studies showed that ssi2 phenotypes were likely due to increased expression of resistance genes. Epistatic analysis suggested that certain components of SA pathway had redundant function and were required for 18:1-regulated signaling.

The aim of the study is the purification and characterization of hemelipoglycoprotein, a carrier protein from the ornate sheep tick Dermacentor marginatus. The protein was characterized by biochemical methods with emphasis on its glycosylation and native molecular weight, and examining its carbohydrate-binding specificity.

No description available.

Protein solution structures were analyzed by horizontal attenuated total reflectance (ATR) FTIR spectroscopy. Secondary structure compositions determined from analyses of amide-I and II region and amide-III region difference spectra were compared. Data for proteins of known solution structure, cytochrome c, concanavalin A and lysozyme, were compared with those reported in the iiterature. Melittin, a peptide from bee venom whose secondary structural configuration varies depending upon solution conditions was also examined. Acyl-carrier protein (ACP) is a small protein of recognized dynamic structure that in its diverse physiologic roles interacts specifically with numerous different proteins. Horizontal ATR FTIR analysis of ACP's secondary structure indicated a predominately helical structure best defined as a combination of ordered and disordered helices. The FTIR-derived structural composition agreed with those determined for ACP by other techniques. Comparison of independent analyses of the amide-I and III regions to determine protein configuration compositions was a useful method of verifying the internal consistency of the calculated structural compositions of dynamically-structured proteins.

The expression of the <I>glycogen phosphorylase- 2</I> gene (<I>gp2</I>) is initiated during early development and regulated by the extracellular morphogens cAMP and Differentiation Inducing Factor (DIF-1) [1-3]. Glycogen phosphorylase- 2 catalyzes the breakdown of glycogen reserves in developing cells to generate glucose precursors required for the synthesis of the end products of differentiation [4-6]. Thus, the expression of <I>gp2</I> is a significant event for cellular differentiation. The sequence of the <I>gp2</I> promoter, like other <I>Dictyostelium</I> promoters, has an AT-rich bias (88%) [7]. Previous deletional analyses of the promoter provided a map of the regions that contained transcriptional regulatory elements. The regions thus identified contained either "TAAAAATGGA" or C-rich repeat sequences [2]. These regions were dissected further by site-directed mutagenesis (SDM) to better define the physical boundaries of the regulatory elements. It was shown that the mutation of either one of the C-rich repeats resulted in a dramatic drop of about 95% in reporter gene levels. These data strongly suggested that both the C-rich repeats of <I>gp2</I> functioned as transcriptional regulatory elements. I have identified and purified a factor called TF2 that demonstrates a high specificity for a C-rich transcriptional regulatory element, the 5' C box. TF2 was first detected with electrophoretic mobility shift assays of DEAE chromatographic fractions of cell-free extracts. The specificity of TF2 for the 5' C box was tested by competition analysis using six other oligonucleotides. Purification of TF2 was achieved by ion-exchange chromatography, DNA affinity chromatography, gel filtration chromatography, and preparative SDS-PAGE. SDS-PAGE analysis indicated an apparent subunit molecular weight of 28 kDa. The apparent molecular weight of the native protein as estimated by gel filtration was about 53 kDa. This suggested that TF2 binds gp2 as a homodimer. A cDNA clone of the tf2 gene was provided by the Japanese <I>Dictyostelium</I> cDNA project. This allowed me to synthesize probes for Southern and Northern blot analyses. Southern blot analysis indicated that there is only one form of the <I>tf2</I> gene. Northern analysis showed little or no expression of <I>tf2</I> in undifferentiated cells. During development <I>tf2</I> expression increases up to a maximum at 8 h, then decreases in later stages. Attempts to disrupt the gene suggest that <I>tf2</I> mutation may be lethal. / Ph. D.